British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. ... more 
British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China. less 
1 / 26
Reuters Videos
Tue, Oct 8, 2013 12:17 PM EDT